Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion

PHASE3RecruitingINTERVENTIONAL

Enrollment

422

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Central Retinal Artery Occlusion

Interventions

DRUG

Tenecteplase (until trial protocol V04: Alteplase)

Intravenous thrombolysis within 4.5 hours of symptom onset

Trial Locations (1)

RECRUITING

University Hospital Tuebingen, Tübingen

All Listed Sponsors

lead

University Hospital Tuebingen

OTHER